INIS
anticoagulants
25%
aspirin
25%
balances
50%
comparative evaluations
25%
coronaries
75%
drugs
25%
elevation
100%
interventions
75%
ischemia
25%
myocardial infarction
100%
optimization
25%
patients
75%
reviews
100%
risks
25%
therapy
100%
thrombosis
25%
Keyphrases
Alternative Pathway
25%
Anticoagulant Drugs
25%
Antithrombotic Therapy
50%
Aspirin
25%
Bleeding Complications
25%
Bleeding Risk
25%
Clinical Outcomes
50%
Clopidogrel
25%
Dual Antiplatelet Therapy
25%
Effective Treatment
25%
Ischemic Events
25%
P2Y12 Inhibitors
25%
Pharmacological Therapy
100%
Prasugrel
25%
Primary PCI
25%
Primary Percutaneous Coronary Intervention
75%
Randomized Trial
25%
Review Update
25%
ST-elevation Myocardial Infarction (STEMI)
100%
Thrombosis
25%
Thrombotic Risk
25%
Ticagrelor
25%
Treatment Strategy
25%
Medicine and Dentistry
Acetylsalicylic Acid
25%
Antiplatelet
25%
Antithrombotic
25%
Antithrombotic Therapy
50%
Bleeding
50%
Clopidogrel
25%
Drug Therapy
100%
Percutaneous Coronary Intervention
25%
Prasugrel
25%
Primary Percutaneous Coronary Intervention
75%
ST Segment Elevation Myocardial Infarction
100%
Thrombosis
25%
Ticagrelor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
25%
Anticoagulant Agent
25%
Antiplatelet
25%
Antithrombotic Therapy
50%
Bleeding
50%
Clopidogrel
25%
Pharmacotherapy
100%
Prasugrel
25%
ST Segment Elevation Myocardial Infarction
100%
Thrombosis
25%
Ticagrelor
25%